O’REILLY, D. J.; GOEREE, R. A.; TARRIDE, J.-E.; JANES, C.; PARFREY, P. S. THE UNINTENDED (AND COSTLY) EFFECTS DUE TO THE INTRODUCTION OF AN UNRESTRICTED REIMBURSEMENT POLICY FOR ATYPICAL ANTIPSYCHOTIC MEDICATIONS IN A CANADIAN PUBLIC PRESCRIPTION DRUG PROGRAM: 1996/97 TO 2005/06. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 16, n. 2, 2018. Disponível em: https://jptcp.com/index.php/jptcp/article/view/555. Acesso em: 16 jul. 2024.